IFP Advisors Inc Sells 750 Shares of Amdocs Limited $DOX

IFP Advisors Inc lowered its stake in shares of Amdocs Limited (NASDAQ:DOX) by 32.7% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,544 shares of the technology company’s stock after selling 750 shares during the period. IFP Advisors Inc’s holdings in Amdocs were worth $148,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Quarry LP raised its stake in shares of Amdocs by 42.2% during the 1st quarter. Quarry LP now owns 391 shares of the technology company’s stock worth $36,000 after purchasing an additional 116 shares in the last quarter. Alhambra Investment Management LLC raised its stake in shares of Amdocs by 5.0% during the 2nd quarter. Alhambra Investment Management LLC now owns 2,585 shares of the technology company’s stock worth $236,000 after purchasing an additional 124 shares in the last quarter. MAI Capital Management raised its stake in Amdocs by 9.7% in the 1st quarter. MAI Capital Management now owns 1,625 shares of the technology company’s stock valued at $149,000 after acquiring an additional 144 shares during the period. Farther Finance Advisors LLC raised its stake in Amdocs by 17.5% in the 1st quarter. Farther Finance Advisors LLC now owns 988 shares of the technology company’s stock valued at $90,000 after acquiring an additional 147 shares during the period. Finally, Corbyn Investment Management Inc. MD raised its stake in Amdocs by 0.4% in the 1st quarter. Corbyn Investment Management Inc. MD now owns 38,866 shares of the technology company’s stock valued at $3,556,000 after acquiring an additional 152 shares during the period. Institutional investors own 92.02% of the company’s stock.

Amdocs Stock Up 0.5%

DOX stock opened at $82.94 on Friday. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.22 and a quick ratio of 1.22. The stock has a market capitalization of $9.36 billion, a price-to-earnings ratio of 16.82, a PEG ratio of 1.38 and a beta of 0.51. The business’s fifty day moving average price is $84.41 and its two-hundred day moving average price is $87.41. Amdocs Limited has a fifty-two week low of $78.61 and a fifty-two week high of $95.41.

Amdocs (NASDAQ:DOX) last posted its quarterly earnings data on Wednesday, August 6th. The technology company reported $1.72 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.01. The firm had revenue of $1.14 billion for the quarter, compared to analysts’ expectations of $1.13 billion. Amdocs had a return on equity of 19.66% and a net margin of 11.94%.The company’s quarterly revenue was down 8.4% compared to the same quarter last year. During the same quarter last year, the business earned $1.62 EPS. On average, equities analysts anticipate that Amdocs Limited will post 6.21 earnings per share for the current year.

Amdocs Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be given a $0.527 dividend. The ex-dividend date is Tuesday, September 30th. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.5%. Amdocs’s dividend payout ratio (DPR) is presently 42.80%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on DOX shares. Weiss Ratings restated a “hold (c+)” rating on shares of Amdocs in a research note on Wednesday, October 8th. Wolfe Research started coverage on Amdocs in a research note on Tuesday, July 8th. They issued an “outperform” rating on the stock. Finally, Wall Street Zen upgraded Amdocs from a “hold” rating to a “buy” rating in a research note on Saturday, October 11th. Three research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, Amdocs presently has a consensus rating of “Moderate Buy” and a consensus target price of $108.00.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.